Home Health Care Market

Selected news for the healthcare topic - Home Health Care Market, collected since 11/2017. This healthcare topic shares news with Home Care, GE Healthcare and several others.

Please provide a valid email address.
Shares Healthcare News With (link):
Healthcare Topics
Companies

Selected Headlines

Date Headline (link) Source Relevant Snippet
8/31/2021 Electromed (NYSEAMERICAN:ELMD) Downgraded to Sell at Zacks Investment Research baseballnewssource.com ... bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company’s products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota. “ Separately, Colliers Securities reiterated a buy rating and issued a $21.00 target price on shares of Electromed in a report ...
8/31/2021 Electromed (NYSEAMERICAN:ELMD) Downgraded by Zacks Investment Research to “Sell” com-unik.info ... bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company’s products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota. “ Separately, Colliers Securities restated a buy rating and set a $21.00 target price on shares of Electromed in a research ...
8/30/2021 Zacks Investment Research Lowers Electromed (NYSEAMERICAN:ELMD) to Sell - Mayfield Recorder Mayfield Recorder ... bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company’s products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota. “Get Electromed alerts: Separately, Colliers Securities reissued a buy rating and issued a $21.00 price target on shares of Electromed ...
8/30/2021 Electromed (NYSEAMERICAN:ELMD) Stock Rating Lowered by Zacks Investment Research - Slater Sentinel slatersentinel.com ... bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company’s products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota. “Get Electromed alerts: Separately, Colliers Securities reissued a buy rating and issued a $21.00 price target on shares of Electromed ...
8/29/2021 Electromed (NYSEAMERICAN:ELMD) Stock Rating Lowered by Zacks Investment Research - Stock Observer thestockobserver.com ... bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company’s products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota. “Get Electromed alerts: Separately, Colliers Securities reiterated a “buy” rating and issued a $21.00 price target on shares of ...
8/28/2021 Electromed (NYSEAMERICAN:ELMD) Downgraded to Sell at Zacks Investment Research - Ticker Report Ticker Report ... bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company’s products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota. “Get Electromed alerts: Separately, Colliers Securities reaffirmed a buy rating and set a $21.00 price target on shares of Electromed ...
8/28/2021 New York State Common Retirement Fund Invests $19.58 Million in Concentrix Co. (NASDAQ:CNXC) | Daily Political Daily Political ... bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company’s products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota. “ Get Electromed alerts:Separately, Colliers Securities restated a buy rating and set a $21.00 price objective on shares of Electromed ...
8/24/2021 Home Health Care Market Demand, Competition, Trends, Industry Analysis by Players and Global Forecasts to 2026 vitalnews24.com Home Health Care Market Demand, Competition, Trends, Industry Analysis by Players and Global Forecasts to 2026 Home Health Care Market Report offers an industry-wide analysis of the market, including precise assessment of the demand for the Home Health Care Market and accurate market insights that allow readers to identify the existing opportunities and threats and optimize their investments. It offers the global sector across key regional markets and gives ...
8/11/2021 Home Health Care Market Analysis and Overview of Global Market In Term Of Size, Share, Growth And Development 2020-2025 instanttechnews.com ... been scrutinized in this research report. It presents the 360-degree overview of the competitive landscape of the industries. Thus, helping the companies to understand the threats and challenges in front of the businesses. Home Health Care Market is showing steady growth and CAGR is expected to improve during the forecast period. [More Information Get Free PDF Sample Report Now!] Prominent Players Profiled in the Report are Almost Family, Inc ...
8/8/2021 Electromed (NYSEAMERICAN:ELMD) Rating Lowered to Sell at Zacks Investment Research zolmax.com ... bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company’s products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota. “ Shares of Electromed stock opened at $11.30 on Friday. The firm has a market capitalization of $97.58 million, a PE ...
8/8/2021 Electromed (NYSEAMERICAN:ELMD) Downgraded by Zacks Investment Research to Sell watchlistnews.com ... bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company’s products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota. “Get Electromed alerts: Shares of ELMD stock opened at $11.30 on Friday. Electromed has a 12-month low of $8.10 ...
8/7/2021 Electromed (NYSEAMERICAN:ELMD) Cut to “Sell” at Zacks Investment Research - Ticker Report Ticker Report ... bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company’s products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota. “Get Electromed alerts: ELMD traded down $0.12 during trading hours on Friday, reaching $11.30. 35,528 shares of the stock traded ...
8/7/2021 Air Transport Services Group (NASDAQ:ATSG) Releases Earnings Results, Beats Estimates By $0.08 EPS | Daily Political Daily Political ... bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company’s products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota. “Shares of ELMD stock traded down $0.12 during trading on Friday, hitting $11.30. 35,528 shares of the stock traded hands, compared ...
8/2/2021 Zacks Investment Research Lowers Electromed (NYSEAMERICAN:ELMD) to Sell zolmax.com ... bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company’s products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota. “ Shares of Electromed stock opened at $11.74 on Friday. The company has a market cap of $101.37 million, a price ...
8/2/2021 Electromed (NYSEAMERICAN:ELMD) Lowered to “Sell” at Zacks Investment Research Daily Political ... bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company’s products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota. “ ELMD stock opened at $11.74 on Friday. The stock has a market capitalization of $101.37 million, a P/E ratio ...
8/1/2021 Electromed (NYSEAMERICAN:ELMD) Stock Rating Lowered by Zacks Investment Research - Stock Observer thestockobserver.com ... bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company’s products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota. “Get Electromed alerts: Shares of Electromed stock opened at $11.74 on Friday. The company has a market cap of $101.43 ...
7/31/2021 Electromed (NYSEAMERICAN:ELMD) Downgraded by Zacks Investment Research to “Sell” dispatchtribunal.com ... bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company’s products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota. “ ELMD opened at $11.74 on Friday. Electromed has a 12-month low of $8.10 and a 12-month high of ...
7/24/2021 Electromed (NYSEAMERICAN:ELMD) Upgraded to Hold by Zacks Investment Research - Transcript Daily transcriptdaily.com ... bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company’s products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota. “Get Electromed alerts: Separately, Northland Securities reiterated a buy rating on shares of Electromed in a research note on Thursday ...
7/24/2021 Electromed (NYSEAMERICAN:ELMD) Upgraded to Hold by Zacks Investment Research thelincolnianonline.com ... bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company’s products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota. “ Separately, Northland Securities reissued a buy rating on shares of Electromed in a research report on Thursday, March 25th. [Electromed ...
7/23/2021 Electromed (NYSEAMERICAN:ELMD) Upgraded at Zacks Investment Research baseballnewssource.com ... bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company’s products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota. “ Separately, Northland Securities restated a buy rating on shares of Electromed in a research report on Thursday, March 25th. [NYSEAMERICAN ...